Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease - 14/04/20
Doi : 10.1016/j.jaad.2020.02.043
Partik Singh, MD, MBA a, Jonathan I. Silverberg, MD, MPH, PhD b, ⁎ 
a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
b Department of Dermatology, George Washington University, Washington, DC
∗Correspondence to: Jonathan I. Silverberg, MD, PHD, MPH, Department of Dermatology, The George Washington University School of Medicine, 2150 Pennsylvania Ave, Ste 2B-430, Washington, DC 20037Department of DermatologyThe George Washington University School of Medicine2150 Pennsylvania AveSte 2B-430WashingtonDC20037
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Tuesday 14 April 2020
| Funding sources: This publication was made possible with support from the Dermatology Foundation. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?